The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The DSMB recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114 in what is being ...
read more
CTD Holdings has filed supporting data for its patent application titled “Methods for Treating Alzheimer’s Disease.”
read more
Wednesday, August 14, 2019
Regeneron announced positive pivotal Phase 3 results for evinacumab, an investigational angiopoietin-like 3 antibody, in patients with homozygous ...
read more
Wednesday, August 14, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a patient in the GBM AGILE Trial, a novel trial design and architecture made possible by ...
read more
Alexion announced the EC has approved the extension of the current marketing authorization of SOLIRIS to include the treatment of NMOSD in adult ...
read more
Wednesday, August 28, 2019
AstraZeneca Pharmaceuticals
AstraZeneca has announced positive results from the Phase III ETHOS trial for triple-combination therapy Breztri Aerosphere in patients with moderate ...
read more
Thursday, August 29, 2019
AbbVie announced a Phase 3 trial evaluating Rova-T as a first-line maintenance therapy for advanced SCLC demonstrated no survival benefit at a pre-...
read more
The Lupus Research Alliance has announced a potential new medicine for lupus, anifrolumab, reduced disease activity versus placebo in a second Phase ...
read more
Acurx announced ACX-362E has successfully completed the 68-subject, double-blind, placebo-controlled, multiple-ascending dose Phase 1 clinical trial ...
read more
Tuesday, September 03, 2019
The recently completed study did not meet its primary endpoint of demonstrating superiority in Clinical Cure rates on Day 21 compared to placebo.
read more
Tuesday, September 03, 2019
SutroVax received an award from CARB-X to develop a universal vaccine to prevent infections caused by Group A Strep bacteria, which include ...
read more
Thursday, September 05, 2019
ZyVersa announced advancements in development of our lead inflammasome inhibitor candidate, IC 100.
read more
Monday, September 09, 2019
Ridgeback Biotherapeutics announced the FDA has recently granted mAb114, an experimental treatment for Ebola, Breakthrough Therapy designation.
read more
Tuesday, September 10, 2019
Biohaven announced completion of enrollment in its Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally ...
read more
Tuesday, September 10, 2019
Glenmark has been granted final approval by the FDA for Clobetasol Propionate Foam, 0.05%, a generic version of Olux®1-E Foam, 0.05%, of Mylan.
read more